Case 4 History. 58 yo man presented with prox IP joint swelling 2 months later pain and swelling in multiple joints Chest radiograph: bi-basilar

Similar documents
Unpaid scientific collaborator & advisor with Veracyte, Inc.

CTD-related Lung Disease

NONE OVERVIEW FINANCIAL DISCLOSURES UPDATE ON IDIOPATHIC PULMONARY FIBROSIS/IPF (UIP) FOR PATHOLOGISTS. IPF = Idiopathic UIP Radiologic UIP Path UIP

Non-neoplastic Lung Disease II

Liebow and Carrington's original classification of IIP

Disclosures. Fibrotic lung diseases: Basic Principles, Common Problems, and Reporting. Relevant financial relationships: None. Off-label usage: None

11/10/2014. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. Radiology

Pathologic Assessment of Interstitial Lung Disease

Usual Interstitial pneumonia and Nonspecific Interstitial Pneumonia. Nitra and the Gangs.

Financial disclosure COMMON DIAGNOSES IN HRCT. High Res Chest HRCT. HRCT Pre test. I have no financial relationships to disclose. Anatomy Nomenclature

5/9/2015. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. No, I am not a pulmonologist! Radiology

Pulmonary manifestations of CTDs Diagnosis, differential diagnosis and treatment

I don t need you. Disclosure Statement. Pathology Approach to ILD 11/5/2016. Kirk D. Jones, MD UCSF Dept of Pathology

Challenges in the Diagnosis of Interstitial Lung Disease

Differential diagnosis

Histopathologic Approach to Interstitial Lung Disease

Bronchoalveolar Lavage and Histopathologic Diagnosis Based on Biopsy

Outline Definition of Terms: Lexicon. Traction Bronchiectasis

Overview of Idiopathic Pulmonary Fibrosis: Diagnosis and Therapy

Replacement of air with fluid, inflammatory. cells or cellular debris. Parenchymal, Interstitial (Restrictive) and Vascular Diseases.

Challenges in the Diagnosis of Interstitial Lung Disease

COI: no conflicts of interest to declare

International consensus statement on idiopathic pulmonary fibrosis

In medicine, the term overlap is very common, to the extent that there is even a

LUNG BIOPSY IN INTERSTITIAL LUNG DISEASE (ILD) AND THE IMPACT OF TRANSBRONCHIAL CRYOBIOPSY

IPF: Epidemiologia e stato dell arte

* * APPROACH TO NON- NEOPLASTIC LUNG DISEASE IN TRANSBRONCHIAL AND SURGICAL BIOPSIES. Financial Disclosures: NONE. BIOPSY TECHNIQUES Bronchoscopic

Connective Tissue Disorder- Associated Interstitial Lung Disease (CTD-ILD) and Updates

The Egyptian Journal of Hospital Medicine (July 2017) Vol.68 (2), Page

Diffuse Interstitial Lung Diseases: Is There Really Anything New?

Pulmonary findings without the influence of therapy in a patient with rheumatoid arthritis : an autopsy case

The radiological differential diagnosis of the UIP pattern

Epidemiology and classification of smoking related interstitial lung diseases

Histopathology of Explanted Lungs from Patients with a Diagnosis of Pulmonary. Sarcoidosis MD 4

Disclosures. Clinical Approach: Evaluating CTD-ILD for the pulmonologist. ILD in CTD. connective tissue disease or collagen vascular disease

Idiopathic Pulmonary Fibrosis: The Importance of Qualitative and Quantitative Phenotyping

Parenchymal, Interstitial i (Restrictive) i and Vascular Diseases

IPF - Inquadramento clinico

Diagnostic challenges in IPF

Progress in Idiopathic Pulmonary Fibrosis

Beyond a consensus classification for idiopathic interstitial pneumonias: progress and controversies

Key words: CT scanners; interstitial lung diseases; polymyositis-dermatomyositis; x-ray

Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparison of the clinicopathologic features and prognosis

Bronkhorst colloquium Interstitiële longziekten. Katrien Grünberg, klinisch patholoog

Case 1 : Question. 1.1 What is the intralobular distribution? 1. Centrilobular 2. Perilymphatic 3. Random

Thoracic lung involvement in rheumatoid arthritis: Findings on HRCT

HYPERSENSITIVITY PNEUMONITIS

UIP Possibile e Probabile

Acute and Chronic Lung Disease

Interstitial Lung Disease ILD: Definition

INTERSTITIAL LUNG DISEASE. Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018

PFF HEALTH CARE PROFESSIONAL WEBINAR SERIES. Welcome!

Diffuse interstitial lung diseases (DILDs) are a heterogeneous group of non-neoplastic, noninfectious

I n 2002 the American Thoracic Society (ATS) and

Bronchoalveolar lavage in fibrotic idiopathic interstitial pneumonias

Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis

Annual Rheumatology & Therapeutics Review for Organizations & Societies

H ypersensitivity pneumonitis (HP) comprises a group of

Manish Powari Regional Training Day 10/12/2014

Case Presentations in ILD. Harold R. Collard, MD Department of Medicine University of California San Francisco

Current diagnostic recommendations for ILD: The multidisciplinary meeting TSANZSRS ASM

NOTICE OF SUBSTANTIAL AMENDMENT

Usual Interstitial Pneumonia (UIP)

I diopathic pulmonary fibrosis (IPF) is the most common

Idiopathic Nonspecific Interstitial Pneumonia Report of an American Thoracic Society Project

Diagnosing Idiopathic Pulmonary Fibrosis on Evidence-Based Guidelines

Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia

Terminal Diffuse Alveolar Damage in Relation to Interstitial Pneumonias An Autopsy Study

Hypersensitivity Pneumonitis Common Diagnostic and Treatment Dilemmas

Idiopathic interstitial pneumonias (IIPs) are a group of

Hypersensitivity Pneumonitis: Epidemiology and Classification

Definition, classification and epidemiology

Idiopathic non-specific interstitial pneumonia: as an autoimmune interstitial pneumonia

CASE OF THE MONTH. Lung Disease in Rheumatoid Arthritis

Systemic lupus erythematosus (SLE): Pleuropulmonary Manifestations

Fibroblastic foci in usual interstitial pneumonia: Idiopathic vs collagen vascular disease

Combined Unclassifiable Interstitial Pneumonia and Emphysema: A Report of Two Cases

A Review of Interstitial Lung Diseases. Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco

INTERSTITIAL LUNG DISEASE Dr. Zulqarnain Ashraf

T he diagnostic evaluation of a patient with

Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease

New lung lesion in a 55 year-old male treated with chemoradiation for non-small cell lung carcinoma

Hypersensitivity Pneumonitis: Spectrum of High-Resolution CT and Pathologic Findings

Diagnosing ILD. What is important in 2016? Chris Grainge

ANDREW G. NICHOLSON, THOMAS V. COLBY, ROLAND M. DUBOIS, DAVID M. HANSELL, and ATHOL U. WELLS

Restrictive lung diseases

UPDATE ON INTERSTITIAL LUNG DISEASE. Thomas V. Colby, M.D.

Radiologic Approach to Smoking Related Interstitial Lung Disease

Histopathologic Subsets of Fibrosing Alveolitis in Patients with Systemic Sclerosis and Their Relationship to Outcome

Guidelines for Diagnosis and Treatment of IPF

Update on Pulmonary Fibrosis

Idiopathic Pulmonary of Care

A Review of Interstitial Lung Diseases

4/17/2010 C ini n ca c l a Ev E a v l a ua u t a ion o n of o ILD U dat a e t e i n I LDs

Chest Radiology Interpretation: Findings of Tuberculosis

Follicular bronchiolitis in surgical lung biopsies: Clinical implications in 12 patients

Imaging: how to recognise idiopathic pulmonary fibrosis

An earlier and more confident diagnosis of idiopathic pulmonary fibrosis

Diagnostic Approach to Advanced Fibrotic Interstitial Lung Disease. Bringing Together Clinical, Radiologic, and Histologic Clues

Transcription:

Case 4 History 58 yo man presented with prox IP joint swelling 2 months later pain and swelling in multiple joints Chest radiograph: bi-basilar basilar infiltrates suggestive of pulmonary fibrosis Open lung biopsy

Case 4 Diagnosis Non-specific interstitial pneumonia (NSIP) occurring in association with rheumatoid arthritis

Pleuropulmonary Manifestations of Rheumatoid Arthritis Pleura: pleuritis, effusions Nodules Airways: bronchiectasis, BOOP, OB Vessels: hypertension, vasculitis Interstitium: NSIP, UIP, L Hyp, DAD, BOOP Drug-induced

Diagnosis of Lung Disease Associated with Connective Tissue Disorders - Challenges Spectrum is broad Few of the histologic lesions are unique May be overlapping pathologic patterns Lung involvement may precede onset of full blown disease? Therapy related direct effect opportunistic infection

Interstitial Disease among 40 RA patients with OL Bx * (%) BOOP 6 (22) UIP 5 (18) LIP/LH 5 (18) NSIP 5 (18) DAD 2 (18) other ILD 4 (15) Total 27 * 13 had RA nodules Yousem SA, Colby TV. Am Rev Resp Dis 1985

Usual Interstitial Pneumonia Pathologically Variegated Process Normal lung Old fibrosis with dense collagen deposition (and honeycomb change) Foci of fibroblast proliferation Architectural Distortion with Bronchiectasis Interstitial inflammation

UIP

Usual Interstitial Pneumonia

UIP

Fib Foci in UIP * * *

* * Fib Foci in UIP *

Non-specific Interstitial Pneumonia A temporal and geographically homogeneous chronic interstitial pneumonia with variable degrees of inflammation and fibrosis but without significant architectural distortion (honeycomb change), granulomatous inflammation or intra-alveolar macrophage accumulation.

NSIP Underlying Diseases and Associations Connective tissue diseases RA, SLE, PM/DM, PSS, SjS Organic antigen exposure Birds, wood stove, grain dust, industrial exposure (paper), vet worker, jacuzzi Autoimmune diseases PBC, Hashimoto s, acute GN Medications 16% Hydralazine, gold, penicillamine 16% Idiopathic 60% 5% 3% Katzenstein and Fiorelli: Am J Surg Pathol 18:136, 1994 CP1040982-1

NSIP

Nonspecific Interstitial Pneumonia/ Fibrosis - Histologic Findings (n = 64) Temporally uniform Patchy, 55% Diffuse, 45% Bronchiolocentric 28% Granulomas 8% Focal BOOP-like areas 48% Katzenstein, Fiorelli.. Am J Surg Pathol 1994, 18:136

NSIP/F - Histopathologic Groups Group 1: Cellular IP, minimal fibrosis (n = 31) Group 2: Cellular IP, moderate fibrosis (n = 24) Group 3: Dense fibrosis/scarring (n = 9) Katzenstein, Fiorelli.. Am J Surg Pathol 1994, 18:136

Cellular NSIP

Cellular NSIP

Cellular and Fibrotic NSIP

Cellular and Fibrotic NSIP

Fibrotic NSIP

Fibrotic NSIP

Survival Following Diagnosis of 100 IPF 80 Survival (%) 60 40 20 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Years following diagnosis Others Nonspecific UIP Bjoraker J et al: Am J Resp Crit Care Med, 1998 CP1095047-2

Nonspecific Interstitial Pneumonia Outcomes in Published Studies 100 Free of disease Alive with disease Dead of disease 80 % 60 40 20 0 Katzenstein 1994 Park et al, 1995 Cottin et al, 1998 Nagai et al, 1998 Daniil et al, 1999 Travis et al, 2000 Nicholson et al, 2000 CP1061069-56

80 60 Nonspecific Interstitial Pneumonia Distribution of Subtypes and Honeycomb Change in Published Studies Cellular NSIP (Group I) Fibrotic NSIP (Group III) % HNCB % 40 20 0 *Not analyzed Katzenstein, 1994 * * Cottin et al, Nagai et al, Travis et al, Nicholson et al, 1998 1998 2000 2000 CP1061069-57

Fibroblast Foci (FiFo) ) in NSIP N % FiFo Katzenstein 64 24 (rare foci) Nagai 31 - Travis 29 55

UIP: Histologic Study of Biopsy and Explant Specimens Areas resembling NSIP commonly occur in a background of otherwise typical UIP. Katzenstein et. al. Am J Surg Pathol 2002;26, 1567

Histopathologic Variability in UIP and NSIP 109 patients with UIP and NSIP who underwent biopsy 2 lobes Concordant UIP (UIP + UIP) 51 NSIP (NSIP + NSIP) 30 Discordant UIP (UIP + NSIP) 28 Flaherty et al AJRCCM 2001;164: 1722

Histopathologic Variability in UIP and NSIP 1.0 NSIP 0.8 Cumulative proportion surviving 0.6 0.4 0.2 Concordant UIP Discordant UIP 0.0 Flaherty et al: AJRCCM, 2001 0 1 2 3 4 5 6 7 8 9 Years CP1047154-2

Inter-observer variation between pathologists in diffuse lung ds Cases referred to Brompton for consult- ation between Jan 96-Dec 97, n=133 circulated to 10 UK pulmonary pathologists Slides, age and gender, site of biopsy Diagnosis weighted kappa UIP 0.59 NSIP 0.40 Mean OP (BOOP) 0.57 0.58 EAA 0.47 Sarcoidosis 0.86 Nicholson AG et al Thorax 2004;59:500-505 505

Difficult UIP Diagnosis Biopsy and Explanted Lungs Compared, n = 20 Katzenstein ALA. Am J Surg Pathol 2002; 26:1567 1. Superimposed DAD 2. Superimposed BOOP 3. Extensive Honeycomb on Biopsy 4. Prominent NSIP-like areas with no or focal honeycomb

Role of the Pathologist in Diagnosing NSIP and UIP on Surgical Biopsies Bx = NSIP You sure? patchwork? HNCB? fib foci? no traps?? I m pretty sure... HRCT = UIP?

Role of HRCT in Separating UIP/IPF from NSIP HRCT Dx Histologic Diagnosis UIP NSIP Total UIP* 27 0 27 Indeterminate 20 5 25 NSIP* 26 (59%) 18 44 *includes definite and probable dx Flaherty et al. Thorax 2003; 58: 143

indeterminate UIP HRCT UIP UIP-NSIP UIP-UIP Path Path + HRCT NSIP NSIP NSIP-NSIP UIP/IPF Role of HRCT in Separating from NSIP (A) HRCT dx of NSIP (dotted line), indeterminate (dashed line), and UIP (solid line), p=0.01 (B) Pathology dx of NSIP (dotted line) and UIP (solid line), p=0.0006 (C) Pathology NSIP and HRCT indeterminate or NSIP (dotted line), pathology UIP and HRCT indeterminate or NSIP (dashed line), and pathology UIP and HRCT UIP (solid line), p=0.001 Flaherty et al. Thorax 2003; 58: 143

Role of the Pathologist in Diagnosing UIP or NSIP in Surgical Biopsies Bx = NSIP You sure? patchwork? HNCB? fib foci? no traps?? I m pretty sure. Probably UIP YES HRCT = UIP? NO NSIP

Interstitial Disease Associated with Connective Tissue Disease What is the frequency of subcategories? Does the histology differ compared to those with idiopathic disease of same subcategory? Does prognosis differ compared to patients with idiopathic disease?

Cellularity of RA assoc vs Idiopathic UIP and NSIP Turesson et al, submitted

Cellularity of RA Turreson assoc vs Idiopathic UIP and NSIP Turesson et al, submitted

Interstitial Disease Associated with Connective Tissue Disease What is the frequency of subcategories? Does the histology differ compared to those with idiopathic disease of same subcategory? Does prognosis differ compared to patients with idiopathic disease?

Mortality in Patients with Lone UIP and RA % mos Lone UIP Bjoraker et al 63 24 RA/UIP Yousem et al 60 20

Survival Amongst Patients with 1.0 LCFA and FA-CTD 0.8 General population Survival 0.6 0.4 LCFA FA-CTD 0.2 0 1 2 3 Years Hubbard and Venn: Rheumatology 41:676, 2002 CP1095047-1

Survival probability 1.0 0.8 0.6 0.4 0.2 CTD/UIP vs IPF/UIP CTD/UIP IPF/UIP 0.0 0 1 2 3 4 5 6 7 8 Years Flaherty et al: Am J Resp Crit Care Med 167:1410, 2003 CP1137209-1

4 IPF/UIP Fibroblast Foci CTD/UIP Fibroblastic foci score 3 2 1 0 0 50 100 150 0 2 4 6 8 10 Lobes Lobes Flaherty et al: Am J Resp Crit Care Med 167:1410, 2003 CP1137209-2

Case 4 Follow-up Treated with immunosuppression including steroids Lung function remained stable x 6 years Died of PE following tx for lymphoma

On to Case 5